omniture
logo
Search
MITOIMMUNE THERAPEUTICS INC.
Media Room

Latest News

rss

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory/Anti-Necrotic Therapy for Oral Mucositis in CCRT patients with Head and Neck Cancer

- MitoImmune initiates a Phase 2 trial of oral mucositis (OM) preventi...

2021-04-06 20:00 2882